Home LiteratureArticle Details
PMID: 12615904 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

The Journal of experimental medicine ·Vol. 197 ·No. 5 ·2003-03-03 ·Pages 633-42

Bartosch B, Dubuisson J, Cosset FL

Abstract

The study of hepatitis C virus (HCV), a major cause of chronic liver disease, has been hampered by the lack of a cell culture system supporting its replication. Here, we have successfully generated infectious pseudo-particles that were assembled by displaying unmodified and functional HCV glycoproteins onto retroviral and lentiviral core particles. The presence of a green fluorescent protein marker gene packaged within these HCV pseudo-particles allowed reliable and fast determination of infectivity mediated by the HCV glycoproteins. Primary hepatocytes as well as hepato-carcinoma cells were found to be the major targets of infection in vitro. High infectivity of the pseudo-particles required both E1 and E2 HCV glycoproteins, and was neutralized by sera from HCV-infected patients and by some anti-E2 monoclonal antibodies. In addition, these pseudo-particles allowed investigation of the role of putative HCV receptors. Although our results tend to confirm their involvement, they provide evidence that neither LDLr nor CD81 is sufficient to mediate HCV cell entry. Altogether, these studies indicate that these pseudo-particles may mimic the early infection steps of parental HCV and will be suitable for the development of much needed new antiviral therapies.

MeSH Terms
Animals Antigens, CD/metabolism Cells, Cultured Genes, Reporter Hepacivirus/physiology Hepatitis C/metabolism Hepatitis C Antigens/immunology,metabolism Hepatocytes/cytology,metabolism,virology Humans Membrane Proteins/metabolism Neutralization Tests Receptors, LDL/metabolism Recombinant Fusion Proteins/genetics,metabolism Tetraspanin 28 Tumor Cells, Cultured Viral Envelope Proteins/immunology,metabolism Viral Structural Proteins/immunology,metabolism Virion/metabolism Virus Assembly
Chemicals
Antigens, CD CD81 protein, human Hepatitis C Antigens Membrane Proteins Receptors, LDL Recombinant Fusion Proteins Tetraspanin 28 Viral Envelope Proteins Viral Structural Proteins protein E1, Classical swine fever virus glycoprotein E2, Hepatitis C virus
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bartosch Birke
Laboratoire de Vectorologie Rétrovirale et Thérapie Génique, Institut National de la Santé et de la Recherche Médicale U412, IFR 128, Ecole Normale Supérieure de Lyon, 69364 Lyon Cedex 07, France.
Dubuisson Jean
Cosset François-Loïc
References (45)
45 references, click to expand
  1. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
    Blood. 2002 Aug 1;100(3):823-32 PMID: 12130492
  2. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
    J Virol. 2002 Sep;76(18):9335-44 PMID: 12186916
  3. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
    Virology. 2000 Nov 25;277(2):358-67 PMID: 11080483
  4. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
    J Gen Virol. 2000 Dec;81(Pt 12):2873-83 PMID: 11086118
  5. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
    J Virol. 1998 May;72(5):3539-46 PMID: 9557633
  6. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
    J Virol. 1999 Aug;73(8):6235-44 PMID: 10400713
  7. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins.
    J Virol. 2002 Jul;76(14):6865-72 PMID: 12072487
  8. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
    J Virol. 2002 Oct;76(19):9673-85 PMID: 12208946
  9. Replication of hepatitis C virus.
    J Gen Virol. 2000 Jul;81(Pt 7):1631-48 PMID: 10859368
  10. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.
    J Virol. 2002 Apr;76(8):4008-21 PMID: 11907240
  11. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins.
    Curr Top Microbiol Immunol. 2000;242:135-48 PMID: 10592659
  12. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.
    EMBO J. 2002 Oct 1;21(19):5017-25 PMID: 12356718
  13. Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system.
    J Virol. 2002 Jan;76(2):912-7 PMID: 11752180
  14. Cellular proteins in HIV virions.
    Rev Med Virol. 1997 Sep;7(3):167-180 PMID: 10398481
  15. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
    J Virol. 2000 Jul;74(13):5933-8 PMID: 10846074
  16. Virus receptors: binding, adhesion strengthening, and changes in viral structure.
    J Virol. 1994 Jan;68(1):1-5 PMID: 8254718
  17. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2.
    J Virol. 1998 Mar;72(3):2183-91 PMID: 9499075
  18. Clinical significance of hepatitis C virus genotypes.
    Clin Microbiol Rev. 2000 Apr;13(2):223-35 PMID: 10755999
  19. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.
    Gene Ther. 2000 Oct;7(19):1613-23 PMID: 11083469
  20. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.
    Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12766-71 PMID: 10535997
  21. Binding of hepatitis C virus to CD81.
    Science. 1998 Oct 30;282(5390):938-41 PMID: 9794763
  22. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization.
    J Biol Chem. 2000 Oct 6;275(40):31428-37 PMID: 10807921
  23. Two point mutations produce infectious retrovirus bearing a green fluorescent protein-SU fusion protein.
    J Virol. 2001 Dec;75(23):11881-5 PMID: 11689670
  24. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
    Science. 1999 Jul 2;285(5424):110-3 PMID: 10390360
  25. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
    Science. 1996 Apr 12;272(5259):263-7 PMID: 8602510
  26. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus.
    J Med Virol. 1999 Mar;57(3):223-9 PMID: 10022791
  27. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.
    J Gen Virol. 2001 Aug;82(Pt 8):1877-83 PMID: 11457993
  28. Lentiviral vectors derived from simian immunodeficiency virus.
    Curr Top Microbiol Immunol. 2002;261:53-74 PMID: 11892253
  29. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins.
    EMBO J. 2002 Jun 17;21(12):2893-902 PMID: 12065403
  30. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
    Cancer Res. 1982 Sep;42(9):3858-63 PMID: 6286115
  31. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.
    J Virol. 1999 Aug;73(8):6782-90 PMID: 10400776
  32. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.
    J Virol. 1998 May;72(5):3827-36 PMID: 9557666
  33. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein.
    J Virol. 2000 Jan;74(2):702-9 PMID: 10623732
  34. Efficient initiation of HCV RNA replication in cell culture.
    Science. 2000 Dec 8;290(5498):1972-4 PMID: 11110665
  35. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes.
    Mol Ther. 2002 Aug;6(2):199-209 PMID: 12161186
  36. Characterization of pseudotype VSV possessing HCV envelope proteins.
    Virology. 2001 Aug 1;286(2):263-75 PMID: 11485395
  37. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.
    Blood. 2002 Apr 1;99(7):2342-50 PMID: 11895766
  38. Mechanisms of enveloped virus entry into animal cells.
    Adv Drug Deliv Rev. 1998 Oct 5;34(1):65-91 PMID: 10837671
  39. Biogenesis of hepatitis C virus envelope glycoproteins.
    J Gen Virol. 2001 Nov;82(Pt 11):2589-95 PMID: 11602769
  40. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
    J Virol. 1994 Oct;68(10):6147-60 PMID: 8083956
  41. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients.
    J Infect Dis. 2002 May 15;185 Suppl 2:S128-37 PMID: 12001034
  42. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
    J Virol. 1998 Aug;72(8):6356-61 PMID: 9658075
  43. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
    Cell. 2001 Sep 7;106(5):539-49 PMID: 11551502
  44. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.
    J Virol. 2002 Jul;76(14):6919-28 PMID: 12072493
  45. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
    J Virol. 2002 Feb;76(3):1181-93 PMID: 11773394
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2003-03-03
Pages
633-42
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193821
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com